369 related articles for article (PubMed ID: 31434683)
1. Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials.
Amanullah I; Khan YH; Anwar I; Gulzar A; Mallhi TH; Raja AA
Postgrad Med J; 2019 Nov; 95(1129):601-611. PubMed ID: 31434683
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Combined Vitamin E and C for Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Poonyam P; Kritsanaviparkporn C; Chommaitree P; Soodcharoen A
Asian Pac J Cancer Prev; 2022 Sep; 23(9):2891-2899. PubMed ID: 36172650
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Sato K; Gosho M; Yamamoto T; Kobayashi Y; Ishii N; Ohashi T; Nakade Y; Ito K; Fukuzawa Y; Yoneda M
Nutrition; 2015; 31(7-8):923-30. PubMed ID: 26059365
[TBL] [Abstract][Full Text] [Related]
4. Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis.
Sarkhy AA; Al-Hussaini AA; Nobili V
Saudi J Gastroenterol; 2014; 20(3):143-53. PubMed ID: 24976277
[TBL] [Abstract][Full Text] [Related]
5. Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
Vadarlis A; Antza C; Bakaloudi DR; Doundoulakis I; Kalopitas G; Samara M; Dardavessis T; Maris T; Chourdakis M
J Gastroenterol Hepatol; 2021 Feb; 36(2):311-319. PubMed ID: 32810309
[TBL] [Abstract][Full Text] [Related]
6. Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis.
Said A; Akhter A
Ann Hepatol; 2017; 16(4):538-547. PubMed ID: 28611274
[TBL] [Abstract][Full Text] [Related]
7. Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
Ji HF; Sun Y; Shen L
Nutrition; 2014 Sep; 30(9):986-91. PubMed ID: 24976430
[TBL] [Abstract][Full Text] [Related]
8. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
[TBL] [Abstract][Full Text] [Related]
9. Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design.
Zang S; Chen J; Song Y; Bai L; Chen J; Chi X; He F; Sheng H; Wang J; Xie S; Xie W; Yang Y; Zhang J; Zheng M; Zou Z; Wang B; Shi J;
Adv Ther; 2018 Feb; 35(2):218-231. PubMed ID: 29411270
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.
Abdel-Maboud M; Menshawy A; Menshawy E; Emara A; Alshandidy M; Eid M
Therap Adv Gastroenterol; 2020; 13():1756284820974917. PubMed ID: 33335561
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of vitamin D supplement in children with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis.
Liu J; Wang T; Chen J; Zhang Y; Yin X; Fan X; Chen Q
Medicine (Baltimore); 2020 Jul; 99(31):e20960. PubMed ID: 32756082
[TBL] [Abstract][Full Text] [Related]
12. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.
Jalali M; Rahimlou M; Mahmoodi M; Moosavian SP; Symonds ME; Jalali R; Zare M; Imanieh MH; Stasi C
Pharmacol Res; 2020 Sep; 159():104799. PubMed ID: 32278041
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
Fatima K; Moeed A; Waqar E; Atif AR; Kamran A; Rizvi H; Suri NF; Haider H; Shuja SH; Khalid M; Minhas AMK
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101816. PubMed ID: 34607067
[TBL] [Abstract][Full Text] [Related]
14. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
Angelico F; Burattin M; Alessandri C; Del Ben M; Lirussi F
Cochrane Database Syst Rev; 2007 Jan; (1):CD005166. PubMed ID: 17253544
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis.
Sawangjit R; Chongmelaxme B; Phisalprapa P; Saokaew S; Thakkinstian A; Kowdley KV; Chaiyakunapruk N
Medicine (Baltimore); 2016 Aug; 95(32):e4529. PubMed ID: 27512874
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials.
Guo XF; Yang B; Tang J; Li D
Clin Nutr; 2018 Feb; 37(1):113-122. PubMed ID: 28161092
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Luo Q; Wei R; Cai Y; Zhao Q; Liu Y; Liu WJ
Front Med (Lausanne); 2022; 9():793203. PubMed ID: 35280867
[TBL] [Abstract][Full Text] [Related]
18. Review article: the management of paediatric nonalcoholic fatty liver disease.
Mitchel EB; Lavine JE
Aliment Pharmacol Ther; 2014 Nov; 40(10):1155-70. PubMed ID: 25267322
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of Vitamin D Supplementation against Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Mansour-Ghanaei F; Pourmasoumi M; Hadi A; Ramezani-Jolfaie N; Joukar F
J Diet Suppl; 2020; 17(4):467-485. PubMed ID: 31256692
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E supplementation in the treatment on nonalcoholic fatty liver disease (NAFLD): Evidence from an umbrella review of meta-analysis on randomized controlled trials.
Wang MY; Prabahar K; Găman MA; Zhang JL
J Dig Dis; 2023; 24(6-7):380-389. PubMed ID: 37503812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
